OHSU in the news

Top CRNA Schools in Oregon

Nurse.org December 14, 2023
OHSU's status as the only certified registered nurse anesthetist school in Oregon is mentioned in a Nurse.org article.

OHSU doctors treat Albany woman with OCD, seizures with brain implant

KGW-TV December 14, 2023
KGW-TV interviews an OHSU patient who is the first person in the world to receive a brain implant to effectively controls two conditions: epileptic seizures and obsessive-compulsive disorder. Her surgeon, Ahmed Raslan, M.D., says: "It's pretty miraculous, to be honest with you, that we ended up where we are."

Groundbreaking Study on Ubiquitin Opens Doors for Disease Prevention and Treatment

Express Healthcare Management December 13, 2023
Research led by Jonathan Pruneda, Ph.D., details the steps taken to create a form of the common protein ubiquitin that has been linked to Parkinson’s disease and breast cancer. Pruneda says this finding is “an important first step,” adding: “We’ll use this knowledge as a foundation or future research including exploring how bacterial take advantage of ubiquitin while infecting cells.”

Groundbreaking Protein Study: A Ray of Hope for Parkinson’s and Breast Cancer Patients

Medriva December 13, 2023
Research led by Jonathan Pruneda, Ph.D., details the steps taken to create a form of the common protein ubiquitin that has been linked to Parkinson’s disease and breast cancer. Pruneda says this finding is “an important first step,” adding: “We’ll use this knowledge as a foundation or future research including exploring how bacterial take advantage of ubiquitin while infecting cells.”

Scientists Uncover How Bacteria Generate Cellular Protein Signals During Infection

Technology Networks December 13, 2023
Research led by Jonathan Pruneda, Ph.D., details the steps taken to create a form of the common protein ubiquitin that has been linked to Parkinson’s disease and breast cancer. Pruneda says this finding is “an important first step,” adding: “We’ll use this knowledge as a foundation or future research including exploring how bacterial take advantage of ubiquitin while infecting cells.”

Weight-loss-drug pioneer: this biochemist finally gained recognition for her work

Nature December 13, 2023
Now in her mid-70s, scientist Svetlana Mojsov is finally getting recognition for her pivotal role in identifying and characterizing the active form of GLP-1, the hormone behind weight-loss drugs Ozempic and Wegovy. Richard Goodman, Ph.D., who helped Mojsov decode the gene as a postdoc, says: "Her contributions were essential. Would it [GLP-1 research] have moved forward without Svetlana? No.”

San Francisco couple leaves $13M gift for cancer research at OHSU

Portland Business Journal December 13, 2023
The estate of George and Helene Ettelson gives an unprecedented gift of nearly $13 million to support cancer and dermatology research at OHSU. Sancy Leachman, M.D., Ph.D., says: “We are incredibly grateful for the continued support from the Ettelson family. This latest gift is the largest gift the department of dermatology has received.”
See more stories